WASHINGTON — An experimental drug might help slow early Alzheimer’s disease in a markedly different way than today’s treatments — by lowering levels of a brain protein called tau, researchers reported Tuesday ... .
). Outlook... The FAWT Consortium will leverage the expertise possessed by each participating company in the joint development of the FAWT, which has the potential to be a game changer for the floating offshore wind industry ... Consortium members. 1 ... 2 ... 3 ... 4 ... 5.
An experimental drug might help slow early Alzheimer's disease in a markedly different way than current treatments — by lowering the brain's production of a protein called tau ... .
These brain scan images provided by Biogen show how high levels of Alzheimer's-related tau protein, in red, dropped in a recipient of the company's experimental drug diranersen. [BIOGEN VIA AP] ... .